Search Ontology:
ChEBI

alpha-Neu5d5N;1,5-lactam-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc6S-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)

Term ID
CHEBI:145767
Synonyms
  • alpha-Neup5N;1,5-lactam-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc6S-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer(d18:1/18:0)
  • N-[(1S,2R,3E)-1-[[[O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[3-O-[(3R,4R,8S)-8-hydroxy-6-oxo-3-[(1R,2R)-1,2,3-trihydroxypropyl]-2-oxa-5-azabicyclo[2.2.2]oct-1-yl]-beta-D-galactopyranosyl-(1->4)]-O-2-(acetylamino)-2-deoxy-6-O-sulfo-beta-D-glucopyranosyl
  • N-[(2S,3R,4E)-1-{[6-deoxy-alpha-L-galactopyranosyl-(1->3)-[3-O-{(3R,4R,8S)-8-hydroxy-6-oxo-3-[(1R,2R)-1,2,3-trihydroxypropyl]-2-oxa-5-azabicyclo[2.2.2]octan-1-yl}-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranosyl-(1->3)-b
  • N-[(2S,3R,4E)-1-{[alpha-L-fucopyranosyl-(1->3)-[3-O-{(3R,4R,8S)-8-hydroxy-6-oxo-3-[(1R,2R)-1,2,3-trihydroxypropyl]-2-oxa-5-azabicyclo[2.2.2]octan-1-yl}-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranosyl-(1->3)-beta-D-galac
Definition
A sialopentaosylceramide consisting of a branched hexasaccharide made up from one lactamized sialyl residue, two galactose residues, one L-fucose residue, one N-acetyl-6-sulfoglucosamine residue and one glucose residue, which at the reducing end is attached to a d18:1/18:0 ceramide moiety via a beta-linkage; commonly known as lactamized sialyl 6-sulfo Lewis X ganglioside.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_part
Phenotype
Phenotype resulting from alpha-Neu5d5N;1,5-lactam-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc6S-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)
Phenotype where environments contain alpha-Neu5d5N;1,5-lactam-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc6S-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)
Phenotype modified by environments containing alpha-Neu5d5N;1,5-lactam-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc6S-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)
Human Disease Model